Polymyalgia Rheumatica – Assessment at Charlottenlund Privathospital

Specialists in rheumatology assess polymyalgia rheumatica on an outpatient basis.

Book an appointment

Polymyalgia rheumatica (PMR) is an inflammatory condition that causes pain and pronounced stiffness in the shoulders, neck, hips and thighs – particularly in the morning – in people over the age of 50. The condition is caused by inflammation in the joints, bursae and tendon sheaths around the shoulder and hip girdles, rather than in the muscles themselves, and is associated with elevated inflammatory markers in the blood. The diagnosis is based on symptoms, blood tests and ultrasound after other conditions have been ruled out. At Charlottenlund Privathospital, polymyalgia rheumatica is assessed by specialists in rheumatology at Jægersborg Allé 4 in Charlottenlund, while treatment is provided in a hospital setting in accordance with current guidelines.

What is polymyalgia rheumatica?



Despite its name, polymyalgia rheumatica is not a disease of the muscles. According to the Danish Society for Rheumatology’s national treatment guidelines, the condition involves inflammation of structures around the shoulder and hip joints – including joint capsules, bursae and tendon sheaths – causing the characteristic pain and stiffness in the shoulder and hip regions. The condition almost exclusively affects people over the age of 50, most commonly those aged 65–70 and above, and is more common in women than in men.

Polymyalgia rheumatica is related to giant cell arteritis (temporal arteritis), an inflammation of the large arteries that can occur at the same time in a minority of patients. For this reason, patients are always asked about headaches, tenderness around the temples, pain when chewing and visual disturbances during the assessment. With appropriate treatment, polymyalgia rheumatica generally has a favourable course, and most patients can discontinue treatment after one to two years.



What are the symptoms of polymyalgia rheumatica?

Typical signs of polymyalgia rheumatica:

  • ✓ Pain and stiffness in both shoulders and upper arms
  • ✓ Often also affecting the neck, hips, buttocks and thighs
  • ✓ Morning stiffness lasting more than 45 minutes
  • ✓ Difficulty raising the arms, getting dressed or standing up
  • ✓ Symptoms developing over a period of days to a few weeks
  • ✓ Fatigue, mild fever, reduced appetite or weight loss

The condition typically develops over a period of days to a few weeks. The main symptoms are pain and stiffness in both shoulders and upper arms, often also affecting the neck, hips, buttocks and thighs. Stiffness is most pronounced in the morning and after periods of rest and may last for more than 45 minutes. Many people find it difficult to raise their arms, get dressed, turn over in bed or stand up from a chair. A general feeling of being unwell, fatigue, mild fever, reduced appetite and weight loss may also occur.

Polymyalgia rheumatica

Assessed on an outpatient basis

Pain and stiffness in the shoulders and hips, elevated inflammatory markers and a clear response to corticosteroid treatment. With appropriate treatment, the condition generally has a favourable course.

Giant cell arteritis

Must be assessed by a doctor on the same day

New-onset headache, tenderness of the scalp or temples, jaw pain when chewing, or temporary or permanent loss of vision. Giant cell arteritis can occur together with polymyalgia rheumatica, and treatment should begin as soon as possible.

Symptoms suggesting concurrent giant cell arteritis include a new-onset headache, tenderness of the scalp or temples, jaw pain when chewing and temporary or permanent visual impairment. These symptoms must be assessed by a doctor on the same day because treatment for giant cell arteritis should begin as soon as possible.


What causes polymyalgia rheumatica?


The cause is unknown. Age is the strongest risk factor, and genetic factors also play a role. The condition is caused by an inflammatory reaction in the tissues surrounding the large joints, and the inflammation can be detected in blood tests as elevated CRP and erythrocyte sedimentation rate (ESR). Polymyalgia rheumatica is not caused by overuse or wear and tear and is not related to osteoarthritis, although both conditions are common in the same age group.


How is polymyalgia rheumatica diagnosed?


Polymyalgia rheumatica is a diagnosis of exclusion: there is no single diagnostic test, and several other conditions can cause similar symptoms. The assessment is based on the medical history – including age, symmetrical symptoms in the shoulder and hip girdles, morning stiffness and sudden onset – combined with a clinical examination, blood tests and ultrasound. According to the international EULAR/ACR classification criteria (2012), factors considered include age over 50, pain in both shoulders, morning stiffness lasting more than 45 minutes, elevated inflammatory markers, negative rheumatological blood tests and ultrasound evidence of inflammation in the shoulder and hip regions.


Blood tests include inflammatory markers, rheumatological markers, thyroid function, muscle enzymes, kidney and liver function tests and haemoglobin. Ultrasound of the shoulders and hips can identify inflammation in the bursae and tendon sheaths, supporting the diagnosis while helping to rule out other causes such as late-onset rheumatoid arthritis, muscle inflammation, thyroid disease, infection and other conditions. If symptoms of giant cell arteritis are present, ultrasound of the temporal arteries and, if necessary, a tissue biopsy may also be performed.



How is polymyalgia rheumatica treated?


1
Consultation and examination

The onset, daily variation and distribution of symptoms are reviewed. The shoulders, hips, joints and range of motion are examined, and the patient is asked about headaches, jaw pain and visual symptoms.

2
Blood tests

Inflammatory markers, rheumatological markers, thyroid function, muscle enzymes, kidney and liver function tests and haemoglobin – taken on the same day.

3
Ultrasound

The shoulders and hips are scanned for inflammation in the bursae and tendon sheaths, while other possible causes are ruled out.

4
Results and referral

If the suspected diagnosis is confirmed, the patient is referred with the completed assessment so that treatment can begin in a hospital setting without delay.

Treatment consists of corticosteroid tablets taken over an extended period, with the dose gradually reduced while symptoms, inflammatory markers and side effects are monitored. According to the latest recommendations from European rheumatology organisations, treatment should be managed in a specialist setting. At Charlottenlund Privathospital, the diagnostic assessment is carried out, while treatment is initiated and monitored in a hospital setting. If the suspected diagnosis is confirmed, the patient is referred with the completed assessment so that treatment can begin without delay.


When should you see a rheumatologist?


A rheumatological assessment may be appropriate for people over the age of 50 who develop new pain and stiffness in both shoulders or hips, particularly when morning stiffness is pronounced, inflammatory markers are elevated or there is a general feeling of being unwell. Assessment may also be appropriate when the diagnosis is uncertain, corticosteroid treatment does not have the expected effect, dose reduction leads to repeated relapses, or side effects require treatment adjustments. Headache, tender temples, jaw pain when chewing or visual disturbances should be assessed on the same day.


Assessment and treatment at Charlottenlund Privathospital



Assessment is carried out by specialists in rheumatology on an outpatient basis. The initial consultation typically lasts around 30 minutes; blood tests and ultrasound of the shoulders and hips can often be performed on the same day. If the diagnosis is confirmed, a treatment and dose-reduction plan is prepared.

Most patients attend through private health insurance. Insurance companies typically require a referral from the patient’s GP and prior authorisation before an appointment is booked. Self-paying patients do not require a referral, and prices are available in the price list. Appointments can be booked online around the clock or by calling 44 98 19 21 Monday to Friday from 08:00 to 14:00. Outside telephone hours, the digital telephone assistant Anna can book, cancel and reschedule appointments.

Frequently asked questions


  • Are polymyalgia rheumatica and muscle rheumatism the same condition?

    Yes. Muskelgigt is the Danish name for polymyalgia rheumatica, often abbreviated to PMR.

  • What is the difference between polymyalgia rheumatica and fibromyalgia?

    Polymyalgia rheumatica is an inflammatory disease that causes elevated inflammatory markers, affects people over 50 and responds to corticosteroids. Fibromyalgia is a chronic pain condition without inflammation, often develops at a younger age and does not respond to corticosteroids.

  • Can polymyalgia rheumatica be detected with a blood test?

    Inflammatory markers CRP and ESR are typically elevated, but they are not specific to polymyalgia rheumatica. Blood tests are used alongside symptoms and ultrasound, and to rule out other conditions.

  • How long does treatment for polymyalgia rheumatica last?

    Treatment is long term, with gradual tapering, and is managed by the hospital. Some people need treatment for longer, and relapses during tapering are common.

  • What happens if polymyalgia rheumatica is left untreated?

    Symptoms persist and affect daily functioning and sleep, and there is a greater risk of missing coexisting giant cell arteritis. With treatment, symptoms usually improve quickly, which is why referral should not be delayed.

  • What is giant cell arteritis?

    Inflammation of the large arteries, especially the temporal arteries, which can occur alongside polymyalgia rheumatica. Headache, tender temples, jaw pain when chewing and visual disturbances are warning signs that require medical assessment the same day.

  • Is polymyalgia rheumatica treated at Charlottenlund Privathospital?

    Your assessment takes place here; treatment with corticosteroids is started and monitored by the hospital following referral with the completed assessment.

  • Is polymyalgia rheumatica hereditary?

    Hereditary factors increase the risk somewhat, but the disease is not directly inherited. Age is the most important risk factor.

  • Can you exercise with polymyalgia rheumatica?

    Yes. When treatment is working, regular physical activity is recommended. It can also help counter corticosteroid side effects such as muscle loss and osteoporosis.

  • Do I need a referral to be assessed for polymyalgia rheumatica at Charlottenlund Privathospital?

    If you are using health insurance, your insurer will typically require a referral from your GP and prior authorisation. No referral is needed if you are paying for your treatment yourself.